Elucidating the precise pharmacological mechanism of action (MOA) of naturally occurring compounds is usually challenging. Although Tarselli et al. (60) produced the 1st de novo synthetic pathway to conolidine and showcased that this naturally developing compound effectively suppresses responses to each chemically induced and inflammation-derived pain, the pharmacologic focus https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers